Awake Prone Positioning in Moderate ARDS: A Case Report
Clinics and Practice · 17.08.2026 · 16 (8) · 151
DOI: 10.3390/clinpract16080151 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinics and Practice, online erschienen am 17.08.2026. Verfasst von Kapilan Kalaruban und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Thusis Hospital, 7430 Thusis, Switzerland. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Legionella pneumophila is a rare but severe cause of community-acquired pneumonia and can lead to acute respiratory distress syndrome (ARDS). Awake prone positioning (APP) has been recognized as an effective adjunct for non-intubated patients with hypoxemic respiratory failure, primarily studied in coronavirus disease 2019 (COVID-19) and other ARDS etiologies. Its application in Legionella-associated ARDS remains poorly documented. Therefore, in this work, we present a case of Legionella-associated ARDS successfully managed with APP, high-flow nasal cannula (HFNC), non-invasive ventilation (NIV), levofloxacin, and corticosteroids. Case presentation: A 62-year-old male with multiple comorbidities, including type 2 diabetes mellitus (T2DM) and a history of coronary artery bypass surgery, presented with a 3-day history of productive cough, exertional dyspnea, and general malaise. Oxygen saturation on admission was 90%, with fever and tachycardia. Inflammatory markers were markedly elevated. Chest computed tomography (CT) revealed extensive bilateral pulmonary infiltrates. Despite a negative urinary Legionella antigen test, sputum polymerase chain reaction (PCR) confirmed Legionella pneumophila on day 2. A Horowitz index of 147 mmHg on day 2 established moderate ARDS. The patient was treated with HFNC oxygen therapy, NIV, and APP for up to 12 h daily. Antibiotic therapy was initiated with amoxicillin/clavulanic acid and clarithromycin, subsequently streamlined to levofloxacin upon microbiological confirmation. Methylprednisolone 40 mg/day was administered for 8 days as adjunctive ARDS therapy. The patient demonstrated gradual clinical and respiratory improvement without requiring endotracheal intubation. Follow-up chest CT on day 7 showed regression of bilateral consolidations and ground-glass opacities (GGOs). The patient was transferred to pulmonary rehabilitation on day 11 and completed antibiotic therapy as an outpatient.
Conclusions
This case illustrates the successful use of APP combined with HFNC and NIV alongside standard medical therapies, including appropriate antibiotics and corticosteroids, to avoid intubation in moderate ARDS secondary to Legionella pneumonia. Early initiation of APP may be a valuable strategy in Legionella-associated ARDS in carefully selected patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Thusis Hospital, 7430 Thusis, Switzerland.
- Academic Department of Emergency Medicine, School of Medicine, University of Cyprus, Nicosia 1678, Cyprus.
- Service des Urgences-SMUR, Fribourg Cantonal Hospital (HFR), 1708 Fribourg, Switzerland.
- Department of Emergency Medicine, Inselspital, University Hospital, University of Bern, 3010 Bern, Switzerland.
ORCID-Profile: Vincent Ribordy
Zitieren
APA
Kalaruban, K., Exadaktylos, A., Ribordy, V., & Ziaka, M. (2026). Awake Prone Positioning in Moderate ARDS: A Case Report. Clinics and Practice, 16(8), 151. https://doi.org/10.3390/clinpract16080151
Vancouver
Kalaruban K, Exadaktylos A, Ribordy V, Ziaka M. Awake Prone Positioning in Moderate ARDS: A Case Report. Clinics and Practice. 2026;16(8):151. doi:10.3390/clinpract16080151
BibTeX
@article{Kalaruban2026,
author = {Kalaruban, Kapilan and Exadaktylos, Aristomenis and Ribordy, Vincent and Ziaka, Mairi},
title = {Awake Prone Positioning in Moderate ARDS: A Case Report},
journal = {Clinics and Practice},
year = {2026},
volume = {16},
number = {8},
pages = {151},
doi = {10.3390/clinpract16080151}
}
EUVIMED